Clinical trials
Active, not recruiting Hyperglycemia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Loma Linda University | 1 |
| Pancreatic Cancer Action Network | 1 |
| Salk Institute for Biological Studies | 1 |
| Singapore Institute of Food and Biotechnology Innovation | 1 |
| Thais Cesar | 1 |
| Tulane University | 1 |
| University of Aberdeen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperglycemia | 7 |
| Hyperinsulinism | 2 |
| Chronobiology Disorders | 1 |
| Diabetes Mellitus | 1 |
| Diabetes, Gestational | 1 |
| Dyslipidemias | 1 |
| Glucose Intolerance | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
| Obesity | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.